Bcl2drn/Bcl2drn
either: C57BL/6-Bcl2drn or (involves: C57BL/6JApb * CBA)
|
diluted coat color |
J:104190
|
irregular coat pigmentation |
J:104190
|
Bcl2tm1Dlo/Bcl2tm1Dlo
B6.129P2-Bcl2tm1Dlo
|
abnormal kidney development |
J:73316
|
abnormal kidney mesenchyme morphology |
J:153846
|
abnormal leukopoiesis |
J:73316
|
abnormal lymphocyte physiology |
J:73316,
J:104487
|
abnormal nephrogenic zone morphology |
J:73316
|
decreased body size |
J:73316,
J:104487,
J:153846
|
decreased body weight |
J:153846
|
decreased nephron number |
J:73316
|
decreased spleen weight |
J:153846
|
decreased spleen white pulp amount |
J:153846
|
increased B cell apoptosis |
J:73316
|
increased splenocyte apoptosis |
J:153846
|
increased T cell apoptosis |
J:73316
|
kidney cyst |
J:73316,
J:104487
|
polycystic kidney |
J:73316,
J:153846
|
premature death |
J:73316,
J:104487,
J:153846
|
short ears |
J:73316
|
small metanephros |
J:73316
|
spleen atrophy |
J:153846
|
Bcl2tm1Dlo/Bcl2tm1Dlo
involves: 129P2/OlaHsd * C57BL/6
|
abnormal coat/hair pigmentation |
J:73660
|
abnormal glomerular capillary endothelium morphology |
J:111022
|
abnormal glomerular capsule parietal layer morphology |
J:111022
|
abnormal kidney cortex morphology |
J:73660,
J:111022
|
abnormal kidney corticomedullary boundary morphology |
J:33776
|
abnormal kidney development |
J:33776
|
abnormal kidney medulla morphology |
J:73660
|
abnormal kidney morphology |
J:73660
|
abnormal kidney vasculature morphology |
J:111022
|
abnormal nephrogenic zone morphology |
J:33776
|
abnormal podocyte morphology |
J:111022
|
abnormal renal glomerulus morphology |
J:33776
|
abnormal renal tubule epithelium morphology |
J:73660
|
abnormal T cell differentiation |
J:73660
|
abnormal ureteric bud elongation |
J:33776
|
decreased body size |
J:73660
|
decreased body weight |
J:73660
|
decreased CD8-positive, alpha-beta T cell number |
J:73660
|
decreased glomerular capsule space |
J:111022
|
decreased kidney weight |
J:111022
|
decreased lymphocyte cell number |
J:73660
|
decreased mature B cell number |
J:73660
|
decreased nephron number |
J:33776,
J:111022
|
decreased pre-B cell number |
J:73660
|
decreased renal glomerulus number |
J:33776,
J:73660,
J:111022
|
decreased thymocyte number |
J:73660
|
dilated renal tubule |
J:33776,
J:73660,
J:111022
|
expanded mesangial matrix |
J:111022
|
glomerulosclerosis |
J:111022
|
impaired branching involved in ureteric bud morphogenesis |
J:33776
|
increased kidney apoptosis |
J:33776,
J:111022
|
increased renal glomerulus apoptosis |
J:111022
|
kidney degeneration |
J:111022
|
kidney failure |
J:111022
|
mesangiolysis |
J:111022
|
pale kidney |
J:73660
|
podocyte foot process effacement |
J:111022
|
podocyte hypertrophy |
J:111022
|
polycystic kidney |
J:73660
|
postnatal lethality, incomplete penetrance |
J:73660
|
renal glomerular synechia |
J:111022
|
renal glomerulus hypertrophy |
J:33776,
J:111022
|
renal hypoplasia |
J:33776
|
renal tubule hypertrophy |
J:33776,
J:111022
|
round snout |
J:73660
|
small ears |
J:73660
|
small kidney |
J:33776,
J:73660,
J:111022
|
small ureteric bud |
J:33776
|
Bcl2tm1Irt/Bcl2tm1Irt Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * C57BL/6
|
increased macrophage apoptosis |
J:144243
|
Bcl2tm1Lbox/Bcl2tm1Lbox
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal B cell activation |
J:114637
|
abnormal B cell differentiation |
J:114637
|
decreased B cell number |
J:114637
|
decreased B cell proliferation |
J:114637
|
decreased immature B cell number |
J:114637
|
decreased mature B cell number |
J:114637
|
decreased pre-B cell number |
J:114637
|
increased B cell apoptosis |
J:114637
|
Bcl2tm1Mpin/Bcl2tm1Mpin
involves: 129S2/SvPas * C57BL/6
|
abnormal facial motor nucleus morphology |
J:34326
|
abnormal L3 dorsal root ganglion morphology |
J:34326
|
abnormal optic nerve morphology |
J:54876
|
abnormal superior cervical ganglion morphology |
J:34326
|
abnormal sympathetic neuron morphology |
J:34326
|
decreased body size |
J:34326
|
decreased sensory neuron number |
J:34326
|
increased blood urea nitrogen level |
J:34326
|
increased circulating creatinine level |
J:34326
|
motor neuron degeneration |
J:34326
|
polycystic kidney |
J:34326
|
premature death |
J:34326
|
retina ganglion cell degeneration |
J:54876
|
Bcl2tm1Sjk/Bcl2tm1Sjk
B6;129S2-Bcl2tm1Sjk/J
|
abnormal skeletal muscle fiber type ratio |
J:66494
|
Bcl2tm1Sjk/Bcl2tm1Sjk
involves: 129S2/SvPas * C57BL/6
|
abnormal CD4-positive, alpha beta T cell morphology |
J:15224
|
abnormal CD8-positive, alpha beta T cell morphology |
J:15224
|
abnormal cell adhesion |
J:53123
|
abnormal immune system organ morphology |
J:15224
|
abnormal induced retina neovascularization |
J:96232
|
abnormal kidney interstitium morphology |
J:15224
|
abnormal metanephric mesenchyme morphology |
J:22552
|
abnormal metanephric ureteric bud development |
J:22552
|
abnormal nephrogenic zone morphology |
J:22552
|
abnormal pericyte morphology |
J:96232
|
abnormal primordial ovarian follicle morphology |
J:28173
|
abnormal renal glomerulus morphology |
J:15224
|
abnormal renal tubule epithelium morphology |
J:15224
|
abnormal retina vasculature morphology |
J:96232
|
abnormal spleen morphology |
J:15224
|
abnormal spleen red pulp morphology |
J:15224
|
abnormal spleen white pulp morphology |
J:15224
|
abnormal thymus involution |
J:15224
|
abnormal thymus morphology |
J:15224
|
absent oocytes |
J:28173
|
cachexia |
J:15224
|
decreased B cell number |
J:15224
|
decreased body size |
J:15224
|
decreased double-positive T cell number |
J:15224
|
decreased kidney weight |
J:34504
|
decreased lymphocyte cell number |
J:15224
|
decreased nephron number |
J:22552
|
decreased renal glomerulus number |
J:22552
|
decreased T cell number |
J:15224
|
decreased vascular endothelial cell number |
J:96232
|
delayed kidney development |
J:34504
|
dilated distal convoluted tubule |
J:15224
|
dilated proximal convoluted tubule |
J:15224
|
enlarged kidney |
J:15224
|
hypopigmentation |
J:15224
|
increased blood urea nitrogen level |
J:15224,
J:22552
|
increased circulating creatinine level |
J:15224,
J:22552
|
increased compensatory renal growth |
J:34504
|
increased double-negative T cell number |
J:15224
|
increased kidney apoptosis |
J:34504
|
increased kidney cell proliferation |
J:15224,
J:34504
|
increased metanephric mesenchyme apoptosis |
J:22552
|
increased T cell apoptosis |
J:15224
|
kidney cortex cyst |
J:22552,
J:34504
|
kidney cyst |
J:15224,
J:34504,
J:53123
|
kidney failure |
J:22552
|
kidney medulla cyst |
J:34504
|
pale kidney |
J:15224
|
parietal capsular epithelium metaplasia |
J:15224
|
polycystic kidney |
J:15224,
J:34504
|
postnatal growth retardation |
J:15224
|
postnatal lethality, incomplete penetrance |
J:15224
|
premature death |
J:15224
|
renal hypoplasia |
J:22552,
J:34504
|
round snout |
J:15224
|
short snout |
J:15224
|
small ears |
J:15224
|
small kidney |
J:15224,
J:22552
|
small metanephros |
J:22552
|
small spleen |
J:15224
|
small thymus |
J:15224
|
Bcl2tm1Sjk/Bcl2tm1Sjk Tg(Dct-lacZ)A12Jkn/0
involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA
|
abnormal melanoblast morphology |
J:157070
|
Bcl2tm1Tsu/Bcl2tm1Tsu
involves: 129P2/OlaHsd * ICR
|
abnormal kidney morphology |
J:22391
|
abnormal lymphocyte morphology |
J:22391
|
abnormal small intestinal villus morphology |
J:22391
|
abnormal small intestine crypts of Lieberkuhn morphology |
J:22391
|
abnormal small intestine morphology |
J:22391
|
abnormal T cell physiology |
J:22391
|
absent hair follicle melanin granules |
J:22391
|
decreased body size |
J:22391
|
decreased renal glomerulus number |
J:22391
|
decreased small intestinal villus height |
J:22391
|
dilated distal convoluted tubule |
J:22391
|
dilated proximal convoluted tubule |
J:22391
|
hypopigmentation |
J:22391
|
pale kidney |
J:22391
|
polycystic kidney |
J:22391
|
postnatal growth retardation |
J:22391
|
postnatal lethality, incomplete penetrance |
J:22391
|
premature death |
J:22391
|
small ears |
J:22391
|
small spleen |
J:22391
|
small thymus |
J:22391
|
spleen atrophy |
J:22391
|
thymus atrophy |
J:22391
|
Bcl2tm2.1Lbox/Bcl2+
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal B cell physiology |
J:175730
|
enlarged lymph nodes |
J:175730
|
enlarged spleen |
J:175730
|
increased B cell derived lymphoma incidence |
J:175730
|
increased B cell number |
J:175730
|
increased follicular lymphoma incidence |
J:175730
|
increased immature B cell number |
J:175730
|
increased mature B cell number |
J:175730
|
increased pre-B cell number |
J:175730
|
premature death |
J:175730
|
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal B cell physiology |
J:175730
|
enlarged lymph nodes |
J:175730
|
enlarged spleen |
J:175730
|
increased B cell derived lymphoma incidence |
J:175730
|
increased B cell number |
J:175730
|
increased follicular lymphoma incidence |
J:175730
|
increased immature B cell number |
J:175730
|
increased mature B cell number |
J:175730
|
increased pre-B cell number |
J:175730
|
premature death |
J:175730
|